 |
|
ACTOS (PIOGLITAZONE): NEW THERAPY FOR TYPE 2 DIABETES WITH NOVEL MODE OF ACTION LAUNCHED IN UK
November 07, 2000“Type 2 diabetes is characterised by high blood sugar but also by lipid abnormalities, particularly raised triglycerides and low HDL (so-called good) cholesterol. This spectrum of metabolic imbalance related to insulin resistance together with raised blood pressure is the characteristic signature of most people with Type 2 diabetes. Any compound with the ability to improve this metabolic spectrum has great potential to improve the treatment of Type 2 diabetes” according to Professor John Betteridge, Professor of Endocrinology and Metabolism at University College, London.
Professor Betteridge added “Pioglitazone, from available scientific evidence, reduces insulin resistance helping to address these metabolic concerns”.
Takeda UK Limited today announced that ACTOS® (pioglitazone) is now available in the UK for the treatment of Type 2 diabetes mellitus.
ACTOS is approved for use in the oral combination treatment of Type 2 diabetes mellitus in patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin (in obese patients) or a sulphonylurea (in patients for whom metformin is not tolerated or contraindicated). ACTOS® is taken once daily and is available in 15 and 30 milligram tablets.
Dr David Kerr, Consultant Physician, Bournemouth Diabetes & Endocrinology Centre, The Royal Bournemouth Hospital said “The availability of pioglitazone is good news for both patients and doctors. By improving insulin sensitivity, pioglitazone in combination with metformin and a sulphonylurea significantly reduces blood glucose levels which is vital when trying to manage Type 2 diabetes. In addition, pioglitazone in combination therapy decreased triglycerides and increased high density lipoprotein cholesterol (HDL-C) with no significant effect on low density lipoprotein cholesterol (LDL-C) compared to placebo.”
It is estimated that 1.4 million people in the UK have diabetes.1 Of these, between 75% and 90% have Type 2 diabetes.1 Dr Roger Gadsby a General Practitioner in Warwick commented that “The treatment of Type 2 diabetes is largely a condition managed in primary care. Any therapy, such as pioglitazone, that is taken once a day and is easy to use will be a valuable addition to the physician’s armamentarium. I believe that pioglitazone has these characteristics.”
For further information, please contact:
Tara Mistry (Tel: 020 7345 3419) or Helen Robinson (Tel: 020 7345 3414) at Ogilvy Public Relations Worldwide.
Note to Editors:
Type 2 diabetes
Type 2 diabetes is a chronic illness characterised by an abnormally high level of glucose (sugar) in the blood.
As Type 2 diabetes progresses, the heart, the circulation, the eyes and the kidneys can all be affected and severe complications can arise which may cause severe disability and restrict a patient’s mobility and ability to work.
The cost of treating Type 2 diabetes and its associated complications is projected to total £4.8 billion in 2000. This accounts for approximately 9% of total NHS resources.1
ACTOS®
ACTOS® is a member of the thiazolidinedione class of drugs commonly known as insulin sensitizers or glitazones. ACTOS® helps restore the body’s ability to effectively use its own insulin by reducing insulin resistance, which has been identified as a primary defect in Type 2 diabetes. By improving sensitivity to insulin, ACTOS® in combination with other antidiabetic therapies significantly reduced raised blood glucose levels.
Takeda
Takeda is the largest pharmaceutical company in Japan and is one of the world’s top 20 pharmaceutical companies.
Takeda is committed to the research and development of novel drug therapies. Takeda has been investing in research into diabetes for over 30 years and were the originators of the thiazolidinedione class of drugs and the company is constantly striving to contribute to the treatment of Type 2 diabetes.
Takeda UK Ltd. is a wholly owned subsidiary of Takeda Chemical Industries, Ltd.
References
1. Diabetes UK. Diabetes Fact Sheet. June 2000.
Date of Preparation: October 2000
AC001027b
Ogilvy Public Relations Worldwide
ACTOS is approved for use in the oral combination treatment of Type 2 diabetes mellitus in patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin (in obese patients) or a sulphonylurea (in patients for whom metformin is not tolerated or contraindicated). ACTOS® is taken once daily and is available in 15 and 30 milligram tablets.
Dr David Kerr, Consultant Physician, Bournemouth Diabetes & Endocrinology Centre, The Royal Bournemouth Hospital said “The availability of pioglitazone is good news for both patients and doctors. By improving insulin sensitivity, pioglitazone in combination with metformin and a sulphonylurea significantly reduces blood glucose levels which is vital when trying to manage Type 2 diabetes. In addition, pioglitazone in combination therapy decreased triglycerides and increased high density lipoprotein cholesterol (HDL-C) with no significant effect on low density lipoprotein cholesterol (LDL-C) compared to placebo.”
It is estimated that 1.4 million people in the UK have diabetes.1 Of these, between 75% and 90% have Type 2 diabetes.1 Dr Roger Gadsby a General Practitioner in Warwick commented that “The treatment of Type 2 diabetes is largely a condition managed in primary care. Any therapy, such as pioglitazone, that is taken once a day and is easy to use will be a valuable addition to the physician’s armamentarium. I believe that pioglitazone has these characteristics.”
For further information, please contact:
Tara Mistry (Tel: 020 7345 3419) or Helen Robinson (Tel: 020 7345 3414) at Ogilvy Public Relations Worldwide.
Note to Editors:
Type 2 diabetes
Type 2 diabetes is a chronic illness characterised by an abnormally high level of glucose (sugar) in the blood.
As Type 2 diabetes progresses, the heart, the circulation, the eyes and the kidneys can all be affected and severe complications can arise which may cause severe disability and restrict a patient’s mobility and ability to work.
The cost of treating Type 2 diabetes and its associated complications is projected to total £4.8 billion in 2000. This accounts for approximately 9% of total NHS resources.1
ACTOS®
ACTOS® is a member of the thiazolidinedione class of drugs commonly known as insulin sensitizers or glitazones. ACTOS® helps restore the body’s ability to effectively use its own insulin by reducing insulin resistance, which has been identified as a primary defect in Type 2 diabetes. By improving sensitivity to insulin, ACTOS® in combination with other antidiabetic therapies significantly reduced raised blood glucose levels.
Takeda
Takeda is the largest pharmaceutical company in Japan and is one of the world’s top 20 pharmaceutical companies.
Takeda is committed to the research and development of novel drug therapies. Takeda has been investing in research into diabetes for over 30 years and were the originators of the thiazolidinedione class of drugs and the company is constantly striving to contribute to the treatment of Type 2 diabetes.
Takeda UK Ltd. is a wholly owned subsidiary of Takeda Chemical Industries, Ltd.
References
1. Diabetes UK. Diabetes Fact Sheet. June 2000.
Date of Preparation: October 2000
AC001027b
Ogilvy Public Relations Worldwide
Diabetes Current Events and Diabetes News RSSDiabetes' link to eating disorders explored
Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said.
Double Agents: Penn Researchers Identify Immune Cells That Fight Parasites May Promote Allergies and Asthma
Millions of people in both the developing and developed world may benefit from new immune-system research findings from the University of Pennsylvania School of Veterinary Medicine.
Pancreatic cancer study reveals mechanism initiating disease, in mice
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.
Nitric oxide-releasing wrap for donor organs and cloth for therapeutic socks
Scientists in Texas are reporting development of a first-of-its-kind cloth that releases nitric oxide gas - an advance toward making therapeutic socks for people with diabetes and a wrap to help preserve organs harvested for transplantation.
Study: Kidney disease a big risk for younger, low-income minorities
Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net).
Study Shows Potential for Using Algae to Produce Human Therapeutic Proteins
Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels.
Poll reveals sleep differences among ethnic groups
The 2010 Sleep in America poll released today by the National Sleep Foundation (NSF) reveals significant differences in the sleep habits and attitudes of Asians, Blacks/African-Americans, Hispanics and Whites. It is the first poll to examine sleep among these four ethnic groups.
Drinking sugar-sweetened beverages daily linked to diabetes, cardiovascular disease, increased healthcare costs
More Americans now drink sugar-sweetened sodas, sport drinks and fruit drinks daily, and this increase in consumption has led to more diabetes and heart disease over the past decade, researchers reported at the American Heart Association's 50th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
Low levels of Vitamin D linked to muscle fat, decreased strength in young people
There's an epidemic in progress, and it has nothing to do with the flu. A ground-breaking study published in the March 2010 Journal of Clinical Endocrinology and Metabolism found an astonishing 59 per cent of study subjects had too little Vitamin D in their blood. Nearly a quarter of the group had serious deficiencies (less than 20 ng/ml) of this important vitamin.
Studies on nutrients, gene expression could lead to tailored diets for disease prevention
Personal health recommendations and diets tailored to better prevent diseases may be in our future, just by focusing on genetics.
More Diabetes Current Events and Diabetes News Articles
 |
The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed by Gretchen Becker (Author), Allison B. Goldfine (Foreword) After Gretchen Becker was diagnosed with type 2 diabetes in 1996, she educated herself on every aspect of this chronic condition — by reading medical and scientific books and journals, talking with doctors and listening to her own body. In 2001, she marshaled everything she had learned as a "patient-expert" into the first edition of this book, which she has now completely updated and revised. The First Year®—Type 2 Diabetes uniquely guides you step-by-step through your first year with diabetes, walking you through everything you need to learn and do each day of your first week after diagnosis, each subsequent week of the first month, and each subsequent month of the crucial first year. In clear, concise, accessible language, Becker covers a wide range of practical, medical, and... |
 |
Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes without Drugs by Neal D. Barnard M.D. (Author) Until Dr. Barnard’s scientific breakthrough, most health professionals believed that once you developed diabetes, you were stuck with it—and could anticipate one complication after another, from worsening eyesight and nerve symptoms to heart and kidney problems. But as this groundbreaking work reveals, this simply is not true. In a series of studies—the most recent funded by the National Institutes of Health—Dr. Barnard has shown that it is possible to repair insulin function and reverse type 2 diabetes. By following his scientifically proven, life-changing program, diabetics can control blood sugar three times more effectively than with the standard diet; and cut back on and in some cases eliminate medications while reducing the risk of diabetes complications. "The long... |
 |
Diabetes Health Pack-Nature Made Multivitamin & Mineral Supplement, 60 Packets by Nature Made Nature Made® Diabetes Health Pack provides essential nutrients that may be lacking due to the strain diabetes can often put on the bodys health. Each pack provides a complete, full potency formulation of vitamins, minerals and alpha lipoic acid. |
 |
Blood Sugar 101: What They Don't Tell You About Diabetes by Jenny Ruhl (Author) Based on the award winning Bloodsugar101.com web site, this book explains what peer-reviewed research published in top medical journals has to say about: What is a normal blood sugar? How does diabetes develop? What really causes diabetes? What blood sugar levels cause complications? Must you deteriorate? What diet is right for you? How can you make that diet work? What medications are safe? What supplements lower blood sugar? Written in clear and understandable language, this book provides all the tools needed to understand how blood sugar works and achieve blood sugar health. |
 |
Diabetes For Dummies (For Dummies (Health & Fitness)) by Alan L. Rubin MD (Author) Covers the latest glucose meters and insulin treatments The straight facts on treating diabetes successfully and living a full life Want to know how to manage diabetes? Leading diabetes expert Dr. Alan Rubin gives you reassuring, authoritative guidance in putting together a state-of-the-art treatment program. You'll learn about all the advances in monitoring glucose, the latest medications, and how to develop a diet and exercise plan to stay healthy. You'll also see how to overcome insurance and on-the-job obstacles. Discover how to: Reduce your diabetes risk Understand the different types of diabetes Manage diabetes in children and the elderly Prevent long-term complications Get the support you need |
 |
Tell Me What to Eat If I Have Diabetes: Nutrition You Can Live With by Elaine Magee (Author) Just because you have diabetes doesn't mean you can't enjoy life, eat well, and live healthy! Tell Me What to Eat If I Have Diabetes begins with a detailed, but non-technical overview of diabetes, specifically Type II diabetes. Elaine clearly presents the latest medical findings on what causes diabetes, available treatments, and the dietary implications of this disease. This revised edition of Tell Me What to Eat If I Have Diabetes includes: * How to use an individualized carbohydrate budget. * Practical tips to lower dangerous blood lipids. * Quick guide to understanding and using the glycemic index and glycemic load. * Revolutionary fiber tips (because you can't talk about carbohydrates, Type II diabetes, and great health without factoring in... |
 |
ACCU-CHEK Compact Plus Meter Kit by ACCU-CHEK $40.00 Mail in Rebate and $25.00 Coupons All-In-One Convenience Bright, Easy-To-Read Display No Coding Detachable, Least painful Lancing Device 17 Test Strip Drum Fits Inside (Not Included) What's Inside? Accu-Chek Compact™ Blood Glucose Meter (batteries included with preset time and date) Detachable Accu-chek Softclix Plus Lancing Device (with lancets and clear cap for testing on different area of the body) Accu-chek Compact Blue Control Solution Easy-to-use Instructions (English and Spanish) Carrying Case Self-Test Diary Warranty Card Unique Design - Proven Least Painful * Allows one hand meter operation Use attached or detached One button action No side-to-side lancet motion reduces skin tearing Choice of 11... |
 |
The Official Pocket Guide to Diabetic Exchanges by American Diabetes Association (Author) Every day, every meal, millions and millions of people count on the world-famous Exchange Lists for Meal Planning to make sure they're choosing the right kinds of foods and portion sizes from the various food groups. Now people with diabetes can take the Exchange Lists with them to the grocery store or to restaurants with the Official Pocket Guide to Diabetic Exchanges. Measuring just 3.5" x 6", this little powerhouse is jam-packed with the exact same information found in the standard exchange lists, yet it fits conveniently into a purse or coat pocket. |
 |
Betty Crocker's Diabetes Cookbook: Everyday Meals, Easy as 1-2-3 by Betty Crocker Editors (Author) At last! This special cookbook puts flavor and choice back on the menu for people with diabetes and their families Betty Crocker, America's most trusted friend in the kitchen, has teamed up with the International Diabetes Center (IDC)--one of the leading medical centers--to create an indispensable source of easy-to-make recipes and up-to-the-minute food and nutrition information for the growing numbers of people who have diabetes, more than 15 million of them. Here is the first cookbook to include recipes featuring Carbohydrate Choices--the new, simplified approach to meal planning recommended by the American Diabetes Association. For people who find diet exchanges too hard, too limiting or too much work, this new method is a real breakthrough. Each of the book's 140 recipes... |
 |
Dr. Bernstein's Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars by Richard K. Bernstein (Author) The standard text on living with diabetes, newly revised and updated with all the latest scientific findings. Since its first publication in 1997, DR. BERNSTEIN'S DIABETES SOLUTION has become the treatment of choice in the medical field. In this revised and updated edition of his work, Dr. Bernstein provides an accessible, detailed guide to his revolutionary approach to normalizing blood sugars and thereby preventing or reversing long-term complications of diabetes. He offers the most up-to-date information on new products, medications, and supplements, and outlines a plan to reverse the obesity that underlies most cases of Type II diabetes. Dr. Bernstein discusses breakthrough science and potential cures, and has added information on the new insulins and insulin ... |
| © 2010 BrightSurf.com |